17 alpha-hydroxylase deficiency differential diagnosis: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
! Category | |||
! Disease name | ! Disease name | ||
! . | ! . | ||
! . | ! . | ||
|- | |- | ||
| | | rowspan="2" |Congenital adrenal hyperplasia | ||
| | |'''3-beta-hydroxysteroid dehydrogenase type 2 deficiency''' | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''17-alpha-hydroxylase deficiency''' | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="4" |Disorders with abnormal testicular activity | | rowspan="4" |Disorders with abnormal testicular activity | ||
| | |Gonadal dysgenesis | ||
| | | | ||
| | | | ||
|. | |. | ||
|- | |- | ||
| | |Testicular regression syndrome | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Vanishing testes syndrome | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Persistent Müllerian duct syndrome | ||
| | | | ||
| | | | ||
| Line 47: | Line 46: | ||
|- | |- | ||
| rowspan="4" |Disorders with abnormal androgen synthesis or response | | rowspan="4" |Disorders with abnormal androgen synthesis or response | ||
| | |'''LH receptor defects''' | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |5-alpha-reductase type 2 deficiency | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''Androgen insensitivity''' | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''AMH receptor defect''' | ||
| | | | ||
| | | | ||
Revision as of 15:53, 4 August 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency differential diagnosis On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency differential diagnosis |
|
FDA on 17 alpha-hydroxylase deficiency differential diagnosis |
|
CDC on 17 alpha-hydroxylase deficiency differential diagnosis |
|
17 alpha-hydroxylase deficiency differential diagnosis in the news |
|
Blogs on 17 alpha-hydroxylase deficiency differential diagnosis |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency must be differentiated from other diseases that cause similar clinical features, such as 5-alpha-reductase deficiency and hypogonadism.[1]
Differentiating 17 alpha-hydroxylase deficiency from other Diseases
17 alpha-hydroxylase deficiency must be differentiated from diseases with undervirilization in males. These diseases include androgen insensitivity syndrome,
| Category | Disease name | . | . | |
|---|---|---|---|---|
| Congenital adrenal hyperplasia | 3-beta-hydroxysteroid dehydrogenase type 2 deficiency | |||
| 17-alpha-hydroxylase deficiency | ||||
| Disorders with abnormal testicular activity | Gonadal dysgenesis | . | ||
| Testicular regression syndrome | ||||
| Vanishing testes syndrome | ||||
| Persistent Müllerian duct syndrome | ||||
| Disorders with abnormal androgen synthesis or response | LH receptor defects | |||
| 5-alpha-reductase type 2 deficiency | ||||
| Androgen insensitivity | ||||
| AMH receptor defect |
References
- ↑ Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016